12. STK33 kinase inhibitor BRD-8899 has no effect on KRAS-dependent cancer cells viability

Luo, T.; Masson, K.; Jaffe, J. D.; Silkworth, W.; Ross, N.; Scherer, C.; Scholl, C.; Fr?hling, S.; Carr, S. A.; Stern, A. M.; Schreiber, S. L.; Golub, T. R. Proc. Natl. Acad. Soc., USA 2012, 109, 2860-2865. (as the co-first author)

Prev: 13. Chromatin-targeting small molecules cause class-specific transcriptional changes in pancreatic endocrine cells

Next: 11. Syntheses of α–Pyrones Using Gold-Catalyzed Coupling Reactions